In a Tuesday report, analyst Jarick Seet expects losses at its associates to reduce to $2 million from $5 million in 2017, before turning around with an estimated $1.5 million profit in 2018.
SINGAPORE (Feb 28): RHB is starting coverage of private oncology specialist TalkMed with a “buy” on substantially lower projected FY17 losses at its associates, higher share liquidity and expectations of expansion via acquisitions.
In 2015, TalkMed partnered with TE Asia Healthcare Partners to open Hong Kong Integrated Oncology Centre and Integrated Imaging & Endoscopy Diagnostic Centre (HKIEDC), of which it owns 30%. The partners followed this up with the implementation of several initiatives to ramp up patient load.
